Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, announced that its CEO, Dr. Kevin Rodan Levy, plans to attend HLTH Europe 2026, a major international healthcare conference focused on digital health, innovation, and emerging technologies. The conference is scheduled for June 15-18 in Amsterdam.
Dr. Levy's attendance is part of the company's broader strategic initiatives, including engagement with healthcare industry participants, evaluation of emerging technologies, and exploration of strategic relationships that may support the development and expansion of its digital health ecosystem. The company believes that participation in major international conferences provides valuable opportunities to observe industry trends, strengthen professional networks, and advance its telehealth and AI healthcare platform strategy.
HLTH Europe is expected to convene healthcare executives, innovators, investors, and technology leaders from global markets to discuss healthcare transformation, digital infrastructure, and advancements in healthcare delivery. For Catalyst Crew, this presents an opportunity to engage with these trends and further its long-term positioning.
Dr. Levy stated: "As we continue advancing our digital health and artificial intelligence initiatives, attending major international healthcare events provides valuable opportunities to observe emerging industry trends, engage with healthcare innovators, and further strengthen our long-term strategic positioning."
The company continues to develop its telehealth platform infrastructure, AI healthcare modules, and broader digital health strategy across Latin America and emerging markets. This focus on scalable digital health solutions aims to improve access, efficiency, and care coordination in regions with growing demand for modernized healthcare delivery systems.
Catalyst Crew Technologies is an AI-driven healthcare technology company focused on building an integrated platform through technology development, strategic partnerships, and targeted acquisitions. For more information, visit https://catalystcrewai.com or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
The company's participation in HLTH Europe 2026 underscores its commitment to staying at the forefront of digital health innovation. By engaging with global leaders and evaluating new technologies, Catalyst Crew aims to enhance its platform and expand its footprint in underserved markets. For leaders in business and technology, this signals the company's proactive approach to integrating AI into healthcare delivery, potentially impacting how emerging markets adopt digital health solutions.
